OncoResponse maintains, reviews and enforces a written code of conduct and conflict of interest policies to promote objectivity in research that is free of bias resulting from conflicting financial interests. The Company requires the timely reporting of any significant financial interests that could affect the design, conduct or reporting of the Company’s research or clinical trials. For further information about the Company’s FCOI policy, status or incidents, please contact info@oncoresponse.com, which will be responded to on a timely basis.